Sanofi agrees to settlement payment with the SEC

The U.S. Securities and Exchange Commission (SEC) reports that Sanofi, without admitting or denying findings, has agreed to pay more than $25 million in penalties to settle bribery and corruption charges. Sanofi, a Paris-based pharmaceutical company, was charged with its Kazakhstan and the Middle East subsidiaries making corrupt payments, including bribery "payments to government procurement officials and healthcare providers in order to be awarded tenders and to increase prescriptions of its products."

To read the press release click here.

To read the SEC order click here.